Table 4.
Correlation between RBC cholinesterase (E-AChE) levels and the prognosis of organophosphorus and carbamate poisoning
| Variables | Measure of association | p-value |
|---|---|---|
| RBC cholinesterase levels in units/gram hemoglobin | ||
| The initial dose of atropine (mg) | ρ: –0.653 | <0.001 |
| The total dose of atropine (mg) | ρ: –0.659 | <0.001 |
| Admission in Intensive Care Unit: median (IQR#) of RBC cholinesterase | ||
| Yes | 1.8 (IQR: 0.9, 6.1) | 0.002 |
| No | 14.9 (IQR: 3.7, 40.1) | |
| Moderate to severe POP% severity scale: median (IQR#) of RBC cholinesterase | ||
| Yes | 1.6 (IQR: 0.65, 3.75) | 0.001 |
| No | 8.45 (IQR: 1.93, 37.75) | |
| Duration of hospital stay | ρ: –0.302 | 0.02 |
| Intermediate syndrome: median (IQR#) of RBC cholinesterase | ||
| Yes | 1.65 (IQR: 0.75, 6.95) | 0.06 |
| No | 4.1 (IQR: 1.6, 35.35) | |
ρ: rho-value – Spearman's coefficient of correlation; POP%, peradeniya organophosphorus poisoning (POP) scale, IQR#, interquartile range. Mann–Whitney U test was applied for the comparison of central tendency between two groups